This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations of Richard C Koya in Stem Cell Research
Introduction
Richard C Koya is an accomplished inventor based in Buffalo, NY (US). He has made significant contributions to the field of stem cell research, particularly in the development of methods to enhance the efficacy of cancer treatments. His innovative work focuses on utilizing lentiviral vectors for stem cell reprogramming.
Latest Patents
Richard C Koya holds a patent for a codon-optimized lentiviral vector aimed at stem cell reprogramming. This invention relates to methods and materials that can be used to produce cytotoxic T cells targeting cancer cells expressing the cancer-testis antigen NY ESO-1. The patent includes illustrative embodiments such as peripheral blood stem cells transduced with a lentiviral vector that comprises codon-optimized TCR alpha and beta chain polypeptides specific for NY ESO-1. These gene-modified cells are particularly useful in hematopoietic stem cell transplantation settings for treating patients diagnosed with NY ESO-1 positive cancers. He has 1 patent to his name.
Career Highlights
Richard C Koya is affiliated with the University of California, where he continues to advance his research in the field of cancer immunotherapy. His work has garnered attention for its potential to improve treatment outcomes for patients with specific cancer types.
Collaborations
Richard has collaborated with notable colleagues in his field, including Thinle Chodon and Antoni Ribas. Their combined expertise contributes to the innovative approaches being developed in cancer treatment.
Conclusion
Richard C Koya's contributions to stem cell research and cancer treatment exemplify the impact of innovative thinking in medical science. His work continues to pave the way for advancements in therapies targeting cancer cells.